ORIC-101 robustly inhibits the glucocorticoid pathway and overcomes chemoresistance in triple-negative breast cancer

Zhou, HY; Ye, QP; Pankov, A; Kong, W; Barkund, S; Friedman, LS; Sun, JD; Kabbarah, O

CANCER RESEARCH, 2020; 80 (4):